At-home treatment for erectile dysfunction has obvious appeal. No prescription. No office visits. And, in the case of The Phoenix, the promise of bringing acoustic or shockwave therapy - technology also used in medical practices - into your home.
But does The Phoenix actually work for erectile dysfunction? And is an at-home acoustic wave device really comparable to the shockwave treatments used in clinical studies?
The short answer: there is legitimate research behind low-intensity shockwave therapy for erectile dysfunction, but that does not mean every device marketed as “shockwave therapy” has been proven effective.
That distinction is particularly important when evaluating The Phoenix.
The Phoenix is a handheld acoustic wave device marketed directly to men for home use. The current manufacturer website recommends using the device twice weekly and promotes it as a way to support penile blood flow and erectile function without medication.
The concept sounds straightforward: if shockwave therapy may improve erectile function, why not use a smaller device at home?
The problem is that “shockwave therapy” is not one standardized treatment.
Different devices generate different types of acoustic energy, at different intensities and depths, using different treatment protocols. Those differences matter when trying to determine whether research performed with one device can reasonably be applied to another.
And that brings us to the most important question about The Phoenix.
This is where we become more skeptical.
There is a growing body of published research evaluating low-intensity shockwave therapy (LiSWT or Li-ESWT) for erectile dysfunction. But those studies have generally involved specific medical-grade devices and carefully controlled treatment protocols.
We have not found high-quality, peer-reviewed randomized clinical trials demonstrating that The Phoenix device itself improves erectile function.
That distinction can easily get lost in marketing.
A company may accurately say that shockwave therapy has been clinically studied. But that is not the same as demonstrating that its particular device, energy output and treatment protocol have produced the same outcomes.
Think of it this way: evidence that one laser, ultrasound system or medical device works does not automatically validate every consumer product using a similar underlying technology.
The relevant question isn't simply:
“Does shockwave therapy work?”
It is:
“Was this device, delivering this type and amount of energy using this treatment protocol, shown to work?”
For The Phoenix, that evidence remains limited.
This question deserves a more nuanced answer than either the marketing claims or some of the criticism online would suggest.
There is evidence that low-intensity shockwave therapy can improve erectile function in some men - particularly men with mild-to-moderate vasculogenic ED. But the results across studies are inconsistent, and the optimal device, energy settings, treatment schedule and patient selection have not been firmly established.
Current professional guidelines reflect that uncertainty.
The American Urological Association (AUA) continues to classify low-intensity extracorporeal shockwave therapy for ED as investigational.
European guidance is somewhat more permissive. The European Association of Urology (EAU) concludes that low-intensity shockwave therapy can produce a mild improvement in erectile function in men with vasculogenic ED and gives a weak recommendation for its use in selected patients, including some men who respond poorly to PDE5 inhibitors such as sildenafil (Viagra) or tadalafil (Cialis).
Why the disagreement?
Part of the problem is that studies have used different devices, different forms of acoustic energy, different energy levels, different numbers of treatments and different types of patients. Pooling all of those studies together under the term “shockwave therapy” makes it difficult to determine exactly which protocols work best - and for whom.
So we don't think it is accurate to say that shockwave therapy has been conclusively proven to reverse ED.
We also don't think it is accurate to say that the treatment has no evidence behind it.
The evidence is promising, but still evolving.
At Performance Men's Health, we use shockwave therapy selectively rather than presenting it as a cure-all for erectile dysfunction.
In our clinical experience, appropriately selected men can see meaningful improvement, particularly when impaired penile blood flow appears to be contributing to ED.
But not everyone responds.
That is one reason we believe shockwave therapy makes more sense as part of a broader erectile dysfunction evaluation than as a stand-alone treatment purchased online.
ED can result from - or provide an early clue to - a number of underlying issues, including:
For many men, improving erectile function requires addressing more than blood flow to the penis.
Not necessarily.
One of the biggest problems in this space is terminology.
Focused shockwaves, radial pressure waves and other acoustic-wave technologies are frequently discussed as though they are interchangeable. They aren't.
Focused shockwave devices are designed to deliver acoustic energy to a defined depth within tissue. Radial pressure-wave devices generate their energy differently and distribute it more superficially. Devices can also differ substantially in energy output, pulse characteristics and treatment parameters.
This matters because much of the clinical literature on ED has evaluated specific low-intensity shockwave systems - not simply anything capable of producing an acoustic pulse.
The Phoenix is marketed as an at-home acoustic wave device. Without clinical trials directly evaluating the device, we cannot assume that using The Phoenix at home reproduces the biological effects or clinical outcomes reported with medical-grade systems in published studies.
That doesn't prove The Phoenix doesn't work.
It means we don't have good evidence demonstrating that it does.
That's an important difference.
You'll find plenty of Phoenix reviews online.
Some users report stronger erections, better spontaneous erections or improved response to ED medications. Others report little or no improvement. There are also extensive testimonials on websites selling or promoting the device.
Those experiences may be real, but testimonials aren't clinical trials.
Erectile function naturally fluctuates. Placebo effects can be substantial in sexual-medicine studies, and improvements may also occur because a man simultaneously changes medications, exercises more, loses weight, improves cardiovascular health or begins using a PDE5 inhibitor.
A randomized, sham-controlled study helps separate those effects from the actual effect of a device.
That's why independent research on The Phoenix itself would be much more meaningful than the number of positive consumer reviews it has accumulated.
This is another area where terminology matters.
You may see phrases such as “FDA registered” associated with consumer medical devices.
FDA registration is not the same thing as FDA approval or clearance for treating a particular medical condition.
Registration generally relates to the manufacturer or device being listed with the FDA. It should not be interpreted to mean that the FDA has independently reviewed clinical trials and determined that a product effectively treats erectile dysfunction.
When evaluating any ED device, look beyond phrases such as “FDA registered,” “medical grade” or “clinically proven” and ask a more specific question:
Has this exact device been cleared or approved by the FDA to treat erectile dysfunction based on evidence supporting that indication?
That is much more informative.
Possibly - but expectations matter.
For a man who has already undergone an appropriate evaluation, understands the limitations of the evidence and is comfortable spending the money, trying an at-home device is a personal decision.
Our concern is less about a man experimenting with a device and more about what can be missed when a device replaces an evaluation.
A new change in erectile function - particularly in a man in his 40s, 50s or 60s - can be an early marker of vascular dysfunction.
The penile arteries are small, and erectile problems can sometimes become apparent before more obvious symptoms of cardiovascular disease develop.
That doesn't mean every man with ED has heart disease.
It does mean that simply treating the erection without asking why it changed can miss useful information about a man's overall health.
Based on the available research and our clinical experience, shockwave therapy appears most reasonable to consider in men whose ED has a significant vascular component, particularly mild-to-moderate vasculogenic ED.
It may also be considered in selected men who have had an incomplete response to medications such as tadalafil or sildenafil and are interested in a non-pharmacologic adjunct.
It is less likely to solve erectile dysfunction caused primarily by severe neurologic injury, advanced arterial disease, significant penile fibrosis or other conditions in which the underlying problem isn't likely to respond to improved vascular signaling alone.
This is why patient selection matters as much as the device.
Shockwave therapy is only one option.
Depending on the cause and severity of ED, treatment may include:
Often the best approach isn't choosing one treatment over every other option. It is determining why erectile function has changed and then building treatment around that physiology.
The Phoenix is an interesting consumer device built around a legitimate area of sexual-medicine research.
But those are two separate statements.
Low-intensity shockwave therapy has shown potential to improve erectile function in selected men with vasculogenic ED. The evidence is not definitive, professional guidelines remain mixed, and treatment protocols are not yet standardized.
More importantly, research performed with medical-grade shockwave systems cannot automatically be extrapolated to The Phoenix.
At this time, we have not found strong peer-reviewed clinical evidence demonstrating that The Phoenix itself produces the same outcomes seen with the devices and protocols used in clinical trials.
So our assessment isn't that The Phoenix is necessarily ineffective.
It's that the marketing claims are ahead of the device-specific evidence.
For men interested in shockwave therapy - or any ED treatment - the better starting point is to understand what is causing the erectile dysfunction, what treatments have evidence for that particular problem and what outcome is realistically achievable.
At Performance Men's Health, we take that approach to ED treatment: identify the physiology first, then choose the tools that make sense for the individual patient.
There is not sufficient clinical evidence to conclude that The Phoenix cures erectile dysfunction. Published research suggests low-intensity shockwave therapy may improve erectile function in some men with vasculogenic ED, but those findings should not automatically be applied to an at-home consumer device.
No. Acoustic-wave devices vary considerably in how they generate and deliver energy. Medical shockwave systems, radial pressure-wave devices and home acoustic-wave devices should not automatically be considered equivalent.
Claims such as “FDA registered” should not be confused with FDA approval or clearance for treating erectile dysfunction. Consumers should look specifically at whether a device has FDA authorization for the indication being advertised.
There is legitimate clinical research evaluating low-intensity shockwave therapy for erectile dysfunction, particularly vasculogenic ED. Some studies demonstrate improvement, while others have produced less convincing results. U.S. professional guidance remains cautious, while current European guidelines acknowledge a mild potential benefit in appropriately selected men.
They work differently and aren't necessarily competing treatments. PDE5 inhibitors such as sildenafil and tadalafil have substantially more established evidence and remain first-line therapies for many men with ED. Shockwave therapy may be considered as an adjunct or alternative in selected patients.
Yes. ED and cardiovascular disease share many of the same vascular risk factors, and erectile dysfunction can sometimes precede clinically apparent cardiovascular disease. New or worsening ED is therefore worth evaluating rather than automatically treating as an isolated sexual problem.
There is no single best treatment for every man. The right treatment depends on the cause and severity of ED, cardiovascular and metabolic health, medications, hormone status, treatment preferences and response to previous therapies. A comprehensive evaluation can help determine which options are most likely to work.
Schedule a consultation with the Performance Men's Health team.